RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...

The transition from simple chemistry to the complex biology of molecules that gave rise to life is a puzzle that scientists ...

A new paper published in Nature Biotechnology this week titled, “Template-independent enzymatic synthesis of RNA oligonucleotides,” provides details of a method for synthesizing single-stranded RNA ...

While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and ...

RNA is usually portrayed as a molecule that works deep inside the cell, helping to turn genetic information into proteins.

tRNAs have a distinct cloverleaf secondary structure and an L-shaped tertiary structure. The cloverleaf structure is formed by the folding of the single-stranded tRNA molecule, which is typically ...